SEC Form 4 · accession 0001140361-16-081272
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pentwater Capital Management LP
10% Owner
Period of report
Sep 29, 2016
Accepted (ET)
Sep 30, 2016 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per shareF1 | Sep 29, 2016 | P | 6,500 | $39.49 | A | 3,689,700 | I | By managed account |
| Common Stock, par value $0.001 per shareF1 | Sep 29, 2016 | P | 9,019 | $39.49 | A | 3,698,719 | I | By managed account |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person is the investment manager for PWCM Master Fund Ltd, an exempted company formed in the Cayman Islands, Pentwater Equity Opportunities Master Fund, Ltd., an exempted company formed in the Cayman Islands, Oceana Master Fund, Ltd., an exempted company formed in the Cayman Islands, Amundi Absolute Return Pentwater Fund Plc, a private fund formed in Ireland, Pentwater Event Driven Cayman Fund Limited, an exempted company formed in the Cayman Islands, Pentwater Merger Arbitrage Master Fund LTD, an exempted company formed in the Cayman Islands, and LMA SPC for and on behalf of MAP 98 Segregated Portfolio, a segregated portfolio company formed in the Cayman Islands, which directly own the shares.